EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis

Ayako Tasaki, Akihiro Fukuda, Akiko Kudo iD, Emiko Nishikawa, Nobuchika Koumatsu, Megumi Wada, Jun Okita, Misaki Maruo, Hiroki Uchida, Takeshi Nakata, Kazuhito Itani iD, Hirotaka Shibata iD

Nephrology · 2025

DOI: 10.1111/nep.70003 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Nephrology, 2025. Verfasst von Ayako Tasaki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19, Factor V Deficiency, Autoimmune Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 73‐year‐old Japanese man with chronic kidney disease had no history of abnormal clotting or bleeding. Six days after receiving his third dose of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine (BNT162b2; Pfizer/BioNTech), blood tests showed a marked prolongation of the prothrombin time‐international normalised ratio and activated partial thromboplastin time, as well as a decrease in factor V (FV) activity. Three months later, he required dialysis owing to worsening heart and renal failure. After supplementation with FV, a flexible double‐lumen catheter was inserted, and haemodialysis was initiated without the use of anticoagulants. The patient was found to be positive for FV inhibitors and was diagnosed with autoimmune acquired factor V deficiency (AiFVD). AiFVD is a rare autoimmune disease in which factor V inhibitors decrease FV activity. The patient did not undergo immunosuppressive therapy because he did not have severe bleeding symptoms, and he is currently able to continue dialysis without causing fatal bleeding. FV inhibitors can be induced by bovine thrombin, surgery, and infection, but have also been detected after SARS‐CoV‐2 infection. The development of various acquired coagulation factor inhibitors has been reported after SARS‐CoV‐2 infection or vaccination, but there have been no reports of AiFVD due to SARS‐CoV‐2 vaccination. To the best of our knowledge, this is the first report of AiFVD probably associated with SARS‐CoV‐2 vaccination. Although AiFVD is rare, physicians should be aware of its possibility after SARS‐CoV‐2 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCOVID-19Factor V DeficiencyAutoimmune DiseasesCOVID-19 VaccinesHumansMaleAgedBNT162 VaccineSARS-CoV-2Factor VVaccinationRenal Insufficiency, Chronic

Stichwörter der Autor:innen

acquired factor V deficiencydialysisfactor Vsevere acute respiratory syndrome coronavirus 2vaccination

Substanzen

BNT162 VaccineCOVID-19 VaccinesFactor V

Autor:innen und Institutionen

  • Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.
  • Division of Haematology, Faculty of Medicine, Oita University, Oita, Japan.

ORCID-Profile: Akiko Kudo, Kazuhito Itani, Hirotaka Shibata

Zitieren

APA

Tasaki, A., Fukuda, A., Kudo, A., Nishikawa, E., Koumatsu, N., Wada, M., Okita, J., Maruo, M., Uchida, H., Nakata, T., Itani, K., & Shibata, H. (2025). A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis. Nephrology. https://doi.org/10.1111/nep.70003

Vancouver

Tasaki A, Fukuda A, Kudo A, Nishikawa E, Koumatsu N, Wada M, et al. A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis. Nephrology. 2025. doi:10.1111/nep.70003

BibTeX
@article{Tasaki2025,
  author = {Tasaki, Ayako and Fukuda, Akihiro and Kudo, Akiko and Nishikawa, Emiko and Koumatsu, Nobuchika and Wada, Megumi and Okita, Jun and Maruo, Misaki and Uchida, Hiroki and Nakata, Takeshi and Itani, Kazuhito and Shibata, Hirotaka},
  title = {A First Case Report of Autoimmune Acquired Factor V Deficiency After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination at the Time of Initiating Haemodialysis},
  journal = {Nephrology},
  year = {2025},
  doi = {10.1111/nep.70003}
}
Kostenlos starten →